Healthcare Professionals
Endurant II Stent Graft Systems
EVAR Procedures
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Endurant II
Healthcare Professionals
Endurant II Stent Graft Systems
EVAR Procedures
Choose the AAA proven solution as varied as your patients. The Endurant™ II system family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA). For the past 5 years, the Endurant II stent graft system has been used in 1 out of 2 EVAR cases.* The Endurant™ II stent stent graft has deep clinical experience and favorable clinical outcomes designed to treat both straightforward and challenging anatomy.
All indications related to Endurant II/IIs Stent Graft System are not approved globally. Please check your local regulatory approval status. Refer to the complete Instructions for Use manual of the Endurant II/IIs stent graft system for the indications approved in your geography.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic Europe website.
The Endurant II/IIs stent graft system is indicated for the endovascular treatment of infrarenal or juxtarenal abdominal aortic or aortoiliac aneurysms in patients with the following characteristics:
In addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply:
In addition, for treatment of juxtarenal abdominal aortic or aortoiliac aneurysms with the parallel graft technique, the following patient characteristics apply:
Note: The angle between the aortic and renal artery blood lumen centerlines is the renal take-off angulation. An angle of <90° is associated with a downward-pointed renal artery relative to the trajectory of the aortic centerline.
The Endurant II family:
Endurant IIs stent graft is a three-piece system that:
The Endurant IIs stent graft:
The Endurant II delivery system helps ensure precise control and accurate placement at every stage of deployment:
Tip capture delivery allows precise adjustment of position, proximally or distally, even after deployment of three stent rings. Control the release of the suprarenal stent and anchor pins with the back-end thumb wheel.
Endurant II Delivery System Controlled Deployment
Deployment, capture, and release of the Endurant II stent.
Deployment of the Endurant IIs Stent Graft - (06:34)
View an animation of the Endurant IIs stent graft deployment.
More information (see more)
Less information (see less)
Deployment of the Endurant II Stent Graft - (03:05)
View an animation of the Endurant II stent deployment.
More information (see more)
Less information (see less)
* Data on file at Medtronic.
† Bench test data on file at Medtronic. Bench test data may not be indicative of clinical performance.
‡ Data on file from the 178 de novo patients from the ENGAGE Post-Approval Study (PAS).
§ Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. 2011; 54:601–608.
Instructions for Use
Find this technical manual in the Medtronic Manual Library or in the product labeling supplied with each device.
Use this tool to plan case specifics such as sizing and placement.
723KB
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETBF | 23 | 13 | C | 124 | EE | 18 |
ETBF | 23 | 13 | C | 145 | EE | 18 |
ETBF | 23 | 13 | C | 166 | EE | 18 |
ETBF | 23 | 16 | C | 124 | EE | 18 |
ETBF | 23 | 16 | C | 145 | EE | 18 |
ETBF | 23 | 16 | C | 166 | EE | 18 |
ETBF | 25 | 13 | C | 124 | EE | 18 |
ETBF | 25 | 13 | C | 145 | EE | 18 |
ETBF | 25 | 13 | C | 166 | EE | 18 |
ETBF | 25 | 16 | C | 124 | EE | 18 |
ETBF | 25 | 16 | C | 145 | EE | 18 |
ETBF | 25 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 13 | C | 124 | EE | 18 |
ETBF | 28 | 13 | C | 145 | EE | 18 |
ETBF | 28 | 13 | C | 166 | EE | 18 |
ETBF | 28 | 16 | C | 124 | EE | 18 |
ETBF | 28 | 16 | C | 145 | EE | 18 |
ETBF | 28 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 20 | C | 124 | EE | 18 |
ETBF | 28 | 20 | C | 145 | EE | 18 |
ETBF | 28 | 20 | C | 166 | EE | 18 |
ETBF | 32 | 16 | C | 124 | EE | 20 |
ETBF | 32 | 16 | C | 145 | EE | 20 |
ETBF | 32 | 16 | C | 166 | EE | 20 |
ETBF | 32 | 20 | C | 124 | EE | 20 |
ETBF | 32 | 20 | C | 145 | EE | 20 |
ETBF | 32 | 20 | C | 166 | EE | 20 |
ETBF | 36 | 16 | C | 145 | EE | 20 |
ETBF | 36 | 16 | C | 166 | EE | 20 |
ETBF | 36 | 20 | C | 145 | EE | 20 |
ETBF | 36 | 20 | C | 166 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ESBF | 23 | 14 | C | 103 | EE | 18 |
ESBF | 25 | 14 | C | 103 | EE | 18 |
ESBF | 28 | 14 | C | 103 | EE | 18 |
ESBF | 32 | 14 | C | 103 | EE | 20 |
ESBF | 36 | 14 | C | 103 | EE | 20 |
Distal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
Total Contralateral Covered Length with EII/EIIs Bifurcated† |
Total Ipsilateral Covered Length with EIIs Bifurcated‡ |
|
---|---|---|---|---|---|---|---|---|
ETLW | 16 | 10 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 10 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 10 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 10 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 10 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 13 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 13 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 13 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 13 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 13 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 16 | C | 82 | EE | 14 | 136 | 135-155 |
ETLW | 16 | 16 | C | 93 | EE | 14 | 147 | 146-166 |
ETLW | 16 | 16 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 16 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 16 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 20 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 20 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 20 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 20 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 20 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 24 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 24 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 24 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 24 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 24 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 28 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 28 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 28 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 28 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 28 | C | 199 | EE | 16 | 253 | 252-272 |
* The limb mates with the AUI stent graft on the ipsilateral side.
† These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions For Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.
‡ The 3-5 stent overlap is available only with select limbs. Please refer to the Instructions For Use for more information.
Proximal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETCF | 23 | 23 | C | 49 | EE | 18 |
ETCF | 25 | 25 | C | 49 | EE | 18 |
ETCF | 28 | 28 | C | 49 | EE | 18 |
ETCF | 32 | 32 | C | 49 | EE | 20 |
ETCF | 36 | 36 | C | 49 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETTF | 23 | 23 | C | 70 | EE | 18 |
ETTF | 25 | 25 | C | 70 | EE | 18 |
ETTF | 28 | 28 | C | 70 | EE | 18 |
ETTF | 32 | 32 | C | 70 | EE | 20 |
ETTF | 36 | 36 | C | 70 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETUF | 23 | 14 | C | 102 | EE | 18 |
ETUF | 25 | 14 | C | 102 | EE | 18 |
ETUF | 28 | 14 | C | 102 | EE | 18 |
ETUF | 32 | 14 | C | 102 | EE | 20 |
ETUF | 36 | 14 | C | 102 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETEW | 10 | 10 | C | 82 | EE | 14 |
ETEW | 13 | 13 | C | 82 | EE | 14 |
ETEW | 20 | 20 | C | 82 | EE | 16 |
ETEW | 24 | 24 | C | 82 | EE | 16 |
ETEW | 28 | 28 | C | 82 | EE | 18 |